Sign up to save your podcasts
Or
Share The Cell Tech That Could Transform Aging
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Cell Tech That Could Transform Aging
Guests:
Nabiha Saklayen
CEO and Co-Founder of Cellino
LinkedIn: https://www.linkedin.com/in/nabihasaklayen/
Cellino: https://cellinobio.com/
Vladik Krupalnik
CEO and Co-Founder of RenewalBio
LinkedIn: https://www.linkedin.com/in/vladik-krupalnik-0669b729/
RenewalBio: https://www.renewal.bio/
________
What can regenerative medicine teach us about health, longevity, and personalized medicine?
Phil Newman and Dr. Nina Patrick sit down with biotech pioneers Nabiha Saklayen and Vladik Krupalnik to explore how cutting-edge stem cell technologies are transforming medicine. They discuss how induced pluripotent stem cells (iPSCs) can be scaled for various applications, from rare blood disorders to organ-specific cells, and how these approaches could redefine healthspan and lifespan.
Beyond individual treatments, Nabiha and Vladik share their visions for decentralized, on-demand cell manufacturing, regulatory strategies, and AI-driven platforms that could make personalized regenerative medicine accessible globally. They also highlight how infrastructure, standardization, and investor alignment are shaping the trajectory of longevity-focused biotech.
This conversation combines the science of regenerative medicine with practical insights for anyone interested in extending healthspan, optimizing personalized therapies, and leveraging technology to transform medicine. Subscribe for weekly episodes on longevity science, regenerative medicine, and the innovations shaping our future.
In this episode, you’ll learn:
- How iPSCs are being used to generate blood, liver, heart, and pancreatic cells
- Stepwise strategies for moving from preclinical work to first-in-human trials
- The distinction between science fiction and realistic regenerative therapies
- How decentralized manufacturing can safely bring therapies closer to patients
- Investor perspectives on longevity and regenerative medicine
- How personalized cell therapies may eventually extend human healthspan
If you care about living longer and healthier, and you’re curious about how regenerative medicine could redefine personalized healthcare, this is a conversation you don’t want to miss.
Subscribe for weekly episodes that explore longevity science, healthspan extension, and the breakthrough technologies shaping the future of regenerative and personalized medicine.
__________
Connect with our Hosts:
Phil Newman: https://qrco.de/bgXpNY
Dr. Nina Patrick: https://qrco.de/bgXpKn
View all episodes
By Longevity.TechnologyGuests:
Nabiha Saklayen
CEO and Co-Founder of Cellino
LinkedIn: https://www.linkedin.com/in/nabihasaklayen/
Cellino: https://cellinobio.com/
Vladik Krupalnik
CEO and Co-Founder of RenewalBio
LinkedIn: https://www.linkedin.com/in/vladik-krupalnik-0669b729/
RenewalBio: https://www.renewal.bio/
________
What can regenerative medicine teach us about health, longevity, and personalized medicine?
Phil Newman and Dr. Nina Patrick sit down with biotech pioneers Nabiha Saklayen and Vladik Krupalnik to explore how cutting-edge stem cell technologies are transforming medicine. They discuss how induced pluripotent stem cells (iPSCs) can be scaled for various applications, from rare blood disorders to organ-specific cells, and how these approaches could redefine healthspan and lifespan.
Beyond individual treatments, Nabiha and Vladik share their visions for decentralized, on-demand cell manufacturing, regulatory strategies, and AI-driven platforms that could make personalized regenerative medicine accessible globally. They also highlight how infrastructure, standardization, and investor alignment are shaping the trajectory of longevity-focused biotech.
This conversation combines the science of regenerative medicine with practical insights for anyone interested in extending healthspan, optimizing personalized therapies, and leveraging technology to transform medicine. Subscribe for weekly episodes on longevity science, regenerative medicine, and the innovations shaping our future.
In this episode, you’ll learn:
- How iPSCs are being used to generate blood, liver, heart, and pancreatic cells
- Stepwise strategies for moving from preclinical work to first-in-human trials
- The distinction between science fiction and realistic regenerative therapies
- How decentralized manufacturing can safely bring therapies closer to patients
- Investor perspectives on longevity and regenerative medicine
- How personalized cell therapies may eventually extend human healthspan
If you care about living longer and healthier, and you’re curious about how regenerative medicine could redefine personalized healthcare, this is a conversation you don’t want to miss.
Subscribe for weekly episodes that explore longevity science, healthspan extension, and the breakthrough technologies shaping the future of regenerative and personalized medicine.
__________
Connect with our Hosts:
Phil Newman: https://qrco.de/bgXpNY
Dr. Nina Patrick: https://qrco.de/bgXpKn